AI Article Synopsis

  • Chronic thromboembolic pulmonary hypertension (CTEPH) leads to obstructive ventilatory impairment, even in non-smokers, but the underlying mechanisms remain unclear.
  • A study analyzed 135 CTEPH patients' pulmonary function, revealing a correlation between %FEV and factors like mean pulmonary artery pressure and CTA obstruction score.
  • Results indicated that in patients who underwent pulmonary endarterectomy, %FEV improved in some cases, pointing to a potential link between vascular involvement in CTEPH and obstructive impairment, warranting further research.

Article Abstract

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension caused by persistent thromboembolism of the pulmonary arteries. In clinical practice, CTEPH patients often show obstructive ventilatory impairment, even in the absence of a smoking history. Recent reports imply a tendency for CTEPH patients to have a lower FEV; however, the mechanism underlying obstructive impairment remains unknown.

Methods: We retrospectively analyzed CTEPH patients who underwent a pulmonary function test and respiratory impedance test to evaluate their exertional dyspnea during admission for right heart catheterization from January 2000 to December 2019. We excluded patients with a smoking history to rule out the effect of smoking on obstructive impairment.

Results: A total of 135 CTEPH patients were analyzed. The median FEV/FVC was 76.0%, %FEV had a negative correlation with the mean pulmonary artery pressure and pulmonary vascular resistance and the CT Angiogram (CTA) obstruction score. A multivariate regression analysis revealed that the CTA obstruction score was an independent factor of a lower %FEV. In the 54 patients who underwent pulmonary endarterectomy, %FEV was improved in some cases and was not in some. Mean PAP largely decreased after PEA in the better %FEV improved cases, suggesting that vascular involvement in CTEPH could be associated with spirometry obstructive impairment.

Conclusion: %FEV had a significant correlation with the CTA obstruction score. Obstructive impairment might have an etiological relationship with vascular involvement. Further investigations could shed new light on the etiology of CTEPH.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656012PMC
http://dx.doi.org/10.1186/s12890-021-01779-xDOI Listing

Publication Analysis

Top Keywords

cteph patients
16
vascular involvement
12
pulmonary hypertension
12
obstructive impairment
12
cta obstruction
12
obstruction score
12
chronic thromboembolic
8
pulmonary
8
thromboembolic pulmonary
8
associated spirometry
8

Similar Publications

The main treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) is radical surgery, pulmonary thromboendarterectomy (PEA). However, about 40% of patients with CTEPH are inoperable due to distal pulmonary vascular lesions or the severity of hemodynamic disorders. Almost 30% of patients with CTEPH experience persistent or recurrent pulmonary hypertension after surgery, that requires a drug treatment with PAH-specific drugs.

View Article and Find Full Text PDF

Do low-risk patients really need follow-up after a pulmonary embolism?

J R Coll Physicians Edinb

January 2025

Medical and Respiratory Units, Dumfries and Galloway Royal Infirmary, Dumfries, UK.

Background: The British Thoracic Society recommend that pulmonary embolism (PE) patients with low-risk Pulmonary Embolism Severity Index (PESI) scores are considered for outpatient (OP) management, in settings where robust pathways for follow-up and monitoring exist.

Methods: Retrospective cohort study. We reviewed the electronic records of 109 consecutive PE patients considered appropriate for OP management.

View Article and Find Full Text PDF

Pulmonary arterial hypertension (PAH) is a disease characterized by increased pulmonary vascular resistance and right heart failure, with emerging evidence suggesting a key role for immune dysregulation in its pathogenesis. This study aimed to assess the involvement of lymphocytes, particularly regulatory T cells (Tregs), and the expression of immune checkpoint molecules PD-1 and PD-L1 on peripheral blood subpopulations in patients diagnosed with PAH. The study involved 25 patients; peripheral blood mononuclear cells were isolated and subsequently analyzed using flow cytometry to quantify the Treg cell percentage and evaluate PD-1 and PD-L1 expression across the T and B cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!